X
Indications

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone. Read More

ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years and older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light). 
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used with or without methotrexate.
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis. 
ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older. Close

How to take ENBREL

Learn more about the different injection options below and watch demonstration videos to see how each device works.

The demonstration videos below give you basic information about each injection option for ENBREL. It is important that you thoroughly review the patient Instructions for Use. These instructions cover everything you need to know about how to use ENBREL. The information on this website does not replace the patient Instructions for Use for the injection options discussed below.

Please contact your healthcare provider if you have any questions.

  • ENBREL MINI® WITH AUTOTOUCH CONNECT®
  • ENBREL MINI® WITH AUTOTOUCH®
  • SURECLICK® AUTOINJECTOR
  • PREFILLED SYRINGE
  • SINGLE-DOSE VIAL
​
​
autotouch-connect-autoinjectior

AutoTouch Connect®
Autoinjector

  • Bluetooth® technology lets you
    automatically track injections in
    the Embark® App
  • Light and sound cues let you know
    when injection is complete
  • Progress bar tracks injection from
    start to finish
  • Customizable speed control with
    3 injection speed options
  • Designed so the needle isn’t seen
  • Ease of Use Commendation from
    the Arthritis Foundation
    • Learn more
​

Injection demo

AutoTouch Connect® and the Enbrel Mini® with AutoTouch® autoinjectors function in the same way. However, the AutoTouch Connect® autoinjector has Bluetooth® capability, which allows you to log your injection automatically in the Embark® App. Each AutoTouch Connect® single-dose prefilled cartridge is to be used with the AutoTouch® reusable autoinjector. Not for use in children (ages 4-17) with chronic moderate to severe plaque psoriasis or children with JIA who weigh less than 138 pounds.

Please read the Instructions for Use for complete instructions on how to use Enbrel Mini® with AutoTouch® autoinjector, and see the User Manual for instructions for using the Bluetooth® features of the AutoTouch Connect® autoinjector.

​
enbrel-catridge

Enbrel Mini® Cartridge with AutoTouch® Autoinjector

  • Light and sound cues let you know when injection is complete
  • Progress bar tracks injection from start to finish
  • Customizable speed control with 3 injection speed options
  • Designed so the needle isn’t seen
  • Ease of Use Commendation from the Arthritis Foundation
    • Learn more
​

Enbrel Mini® with AutoTouch® and the AutoTouch Connect™ autoinjectors function in the same way. However, the Enbrel Mini® with AutoTouch® does NOT have Bluetooth® capability, and therefore you must log your injection manually in the Embark® App if you choose to do so. Each Enbrel Mini® single-dose prefilled cartridge is to be used with the AutoTouch® reusable autoinjector. Not for use in children (ages 4-17) with chronic moderate to severe plaque psoriasis or children with JIA who weigh less than 138 pounds.

​

SureClick® Autoinjector

  • Hidden-needle design
  • Device injects medicine with the press of a button
  • Audible click when you start and finish your injection
  • Does not need to be mixed or prepared
  • Each autoinjector is a single dose
  • Ease of Use Commendation from the Arthritis Foundation
  • Not for use in children (ages 4-17) with chronic moderate to severe plaque psoriasis or children with JIA who weigh less than 138 pounds
​
​

Prefilled Syringe

  • Manually injected, which means you control the rate of injection
  • Does not need to be mixed or prepared
  • Ease of Use Commendation from the Arthritis Foundation
  • Each prefilled syringe is a single dose 
  • The 25 mg syringe is not for use in children (ages 4-17) with chronic moderate to severe plaque psoriasis or children with JIA who weigh less than 68 pounds
  • The 50 mg syringe is not for use in children (ages 4-17) with chronic moderate to severe plaque psoriasis or children with JIA who weigh less than 138 pounds
​
​

Single-Dose Vial for Injection

  • Only option available for children (ages 4-17) with chronic moderate
    to severe plaque psoriasis and children with JIA who weigh less
    than 68 pounds
  • Ready to use–no mixing or preparation 
  • Latex-free option

Syringes and needles are
required and not supplied with the single-dose vial and may require a separate prescription from your doctor. We recommend:

  • A 1 mL Luer-Lock syringe
  • A withdrawal needle with Luer-Lock connection, sterile, 22-gauge, length 1 1/2 inch
  • An injection needle with Luer-Lock connection, sterile, 27-gauge, length 1/2 inch

    • Two vials may be required to administer the total prescribed dose. Use the same syringe for each vial. The vial does not contain preservatives; therefore discard unused portions.

​
+ See More

Important Safety Information

What is the most important information I should know about ENBREL?

ENBREL is a medicine that affects your immune

ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections
have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have

 
― Close
Prescription Enbrel® (etanercept) is taken (given) by injection.

Important Safety Information

What is the most important information I should know about ENBREL?

ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB.

There have been some cases of unusual cancers, some resulting in death, reported in children and teenage patients who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma.

Before starting ENBREL, tell your healthcare provider if you:

  • Have any existing medical conditions
  • Are taking any medicines, including herbals
  • Think you have, are being treated for, have signs of, or are prone to infection. You should not start taking ENBREL if you have any kind of infection, unless your healthcare provider says it is okay
  • Have any open cuts or sores
  • Have diabetes, HIV, or a weak immune system
  • Have TB or have been in close contact with someone who has had TB
  • Were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your healthcare provider if you are not sure
  • Live, have lived in, or traveled to certain parts of the country (such as, the Ohio and Mississippi River valleys, or the Southwest) where there is a greater risk for certain kinds of fungal infections, such as histoplasmosis. These infections may develop or become more severe if you take ENBREL. If you don’t know if these infections are common in the areas you’ve been to, ask your healthcare provider
  • Have or have had hepatitis B
  • Have or have had heart failure
  • Develop symptoms such as persistent fever, bruising, bleeding, or paleness while taking ENBREL
  • Use the medicine Kineret (anakinra), Orencia (abatacept), or Cytoxan (cyclophosphamide)
  • Are taking anti-diabetic medicines
  • Have, have had, or develop a serious nervous disorder, seizures, any numbness or tingling, or a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome
  • Are scheduled to have surgery
  • Have recently received or are scheduled for any vaccines. All vaccines should be brought up-to-date before starting ENBREL. Patients taking ENBREL should not receive live vaccines.
  • Are allergic to rubber or latex
  • Are pregnant, planning to become pregnant, or breastfeeding
  • Have been around someone with chicken pox

What are the possible side effects of ENBREL?

ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis.

Common side effects include: Injection site reactions and upper respiratory infections (sinus infections).

In general, side effects in children were similar in frequency and type as those seen in adult patients. The types of infections reported were generally mild and similar to those usually seen in children.

These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away.

If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see Prescribing Information and Medication Guide.

Indications

Moderate to Severe Rheumatoid Arthritis (RA)

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.

Psoriatic Arthritis

ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used with or without methotrexate.

Moderate to Severe Plaque Psoriasis

ENBREL is indicated for chronic moderate to severe plaque psoriasis (PsO) in children 4 years and older and adults who may benefit from taking injections or pills (systemic therapy) or phototherapy (ultraviolet light).

Ankylosing Spondylitis (AS)

ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

Moderately to Severely Active Polyarticular Juvenile Idiopathic Arthritis (JIA)

ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Amgen is under license.

Please see the full Prescribing Information, Important Safety Information, and Medication Guide for more details about ENBREL.

References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm